Invests in
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
Lists including Chase
Investments
Work Experience
2019
Co-Founder
2019
Ostro is an AI company offering the first end-to-end solution for digital commercialization in the life sciences sector. Today, Ostro partners with more than 50% of the top 20 pharma companies as well as many mid-size and smaller pharma manufacturers. We are a team of former Google, Amazon, Microsoft, McKinsey, Hims & Hers, Abbvie, Doximity engineers, life scientists, doctors, designers and product innovators to digitize and provide next-generation software solutions for HCPs, consumers, and life science companies. The company has been covered in the Wall Street Journal, Fortune, Forbes, Adweek, Axios, Endpoints, Fierce Pharma, MM&M, MedCityNews, PM360, PharmaVoice, and many others. Ostro has won numerous awards such as Top 100 Healthcare Technology Companies, MedTech Breakthrough Award, and numerous others from PM360, Fierce, and MM&M for its work in AI in life sciences. www.ostrohealth.com
2018
Contributing Writer
2018
As a contributing writer for Forbes, I've focused on topics primarily in healthcare and manufacturing. I've covered CEOs and executives from companies such as Takeda, Gilead, Jazz, Pfizer, Exact Sciences, and numerous other top pharma, biotech, diagnostics, and device companies. I have a deep passion for the overlapping areas of AI and healthcare.
2024
Co-Editor
2024
Kinara is from life sciences for life sciences. It is more than a content lab - it's a hub for doctors, scientists, and industry leaders pushing the boundaries of life sciences. We offer exclusive insight and firsthand information, giving readers an up-close look at the trends, technologies and pivot points driving the future of the industry. www.kinara.co
2023 - 2024
Sequoia Scout
2023 - 2024
Investing in pre-seed and seed stage AI, Enterprise, Health Tech, and Life Science Software companies
2020 - 2024
Adjunct Lecturer
2020 - 2024
Teaching a course entitled "Disruption and Innovation in the Healthcare Market"
2013 - 2018
Co-Founder
2013 - 2018
Parsable is an enterprise SaaS company, digitizing frontline worker operations for the world's largest industrial companies. The company pioneered the Connected Worker™ market category. The platform powers over $1.6 trillion in annual production revenue across Parsable’s customer base. With Parsable, companies gain unprecedented insight into human work by capturing essential data to improve their operations. A member of the World Economic Forum’s Centre for the Fourth Industrial Revolution, Parsable is trusted by top global companies in the manufacturing, energy, consumer packaged goods, chemical, aerospace, industrial equipment, automotive and packaging industries. Heineken, Suntory Beverage & Food, Engie, Coca-Cola, AB-InBev, Constellation Brands, Holcim, Amazon, American Axle, Grupo Bimbo, Cemex, Daher, Honeywell, Unilever, Bechtel, Airbus, Raytheon and many more have used the Parsable platform to run their business-critical operations. Parsable has had a number of industry partnerships across smart factories, IOT, industry 4.0 initiatives, and more with McKinsey, BCG, SAP, Deloitte, and more. The company’s work has been covered in the New York Times, Wall Street Journal, Fortune, Forbes, Axios, TechCrunch, and more. I left the company to finish my medical degree at Mount Sinai in NYC. Helped scale Parsable from $0M to $250M in enterprise value from 2013 - 2019. Acquired by STG Capital (Private Equity)
2013 - 2018
Partner
2013 - 2018
An operator fund with investments in: Masterclass.com (Series A, B, and C) Thumbtack (Seed, Series A, Series B, Series C) Dynasty.com (Seed) (acq. by NASDAQ: APPF) Rocksbox.com (Seed) (acq. by NYSE:SIG) Howdy.ai/XOXCO (Seed) (acq. by NASDAQ: MSFT) Buddybuild (Seed) (acq. by NASDAQ: AAPL) Mixer Labs (Seed) (acq. by Twitter)
2012 - 2013
Intern
2012 - 2013
First Round Capital is a seed-stage venture fund that has backed industry creating companies such as Uber, Square, Warby Parker, Flatiron Health, Clover Health, Roblox, and more. While in medical school, I provided research and insight to existing portfolio companies and helped conduct due diligence on new potential investments. I left to start Parsable, which First Round Capital led the seed round for.
2011 - 2011
Strategy Consultant
2011 - 2011
Immediately following my graduation from UPenn, I worked as a full-time strategy consultant at Accenture. I left Accenture after being awarded a Trust Scholarship to attend Cambridge University for my Masters.
Research Coordinator
2007 - 2010
August 2010-December 2010 Studied the use of health information technology changes in workflow engendered by clinician (RN) respondents and (MD) respondents September 2009-January 2010 Conducted organizational behavior research in the Neuro ICU, studying how workflow is affected by architecture and health information technologies. Using this research, I co-authored multiple papers November 2007-May 2009 Worked as a research coordinator in the Department of Cardiothoracic Surgery. Most of my work was completed through the IRAD Database Worked in these roles as an undergrad at UPenn. Left in 2010 since I graduated.